💊
Pharmaceutical Biochemistry · Semester 1

Unit 5: Biochemistry of Vitamins

Fat-soluble (A, D, E, K) and water-soluble (B-complex, C) vitamins — coenzyme roles, deficiency diseases, daily requirements.

Unit 5 of 613 minIntermediate
Unit Overview (click to enlarge)
Biochemistry of Vitamins overview

Unit 5: Biochemistry of Vitamins

Introduction to Vitamins

Vitamins are a group of organic compounds that are essential in small amounts for normal growth, metabolism, and physiological function. They cannot be synthesized by the human body in sufficient quantities (or at all) and must be obtained from the diet or supplements. Vitamins do not provide energy but act as essential cofactors in enzymatic reactions, hormones, or antioxidants.

Historical Perspective:

  • The term "vitamine" was coined in 1912 by Casimir Funk (from "vital amine") as he isolated niacin (thought to contain an amine group).
  • Later, when it was found that not all vitamins contain nitrogen, the "e" was dropped to become "vitamin."
  • Discovery of vitamins occurred through studies of deficiency diseases: scurvy (vitamin C), beriberi (thiamine), rickets (vitamin D), pellagra (niacin).

General Characteristics of Vitamins:

PropertyDescription
EssentialityCannot be synthesized in adequate amounts by the body
Required amountsSmall quantities (micrograms to milligrams daily)
FunctionUsually as coenzymes, hormones, or antioxidants
DeficiencyLeads to specific deficiency diseases
ToxicityPossible with excessive intake, especially fat-soluble vitamins

1. Classification of Vitamins

Vitamins are classified based on their solubility, which affects their absorption, transport, storage, and excretion.

1.1 Fat-Soluble Vitamins (A, D, E, K)

PropertyCharacteristics
SolubilitySoluble in fats and organic solvents; insoluble in water
AbsorptionAbsorbed along with dietary fats (require bile salts, pancreatic lipase)
TransportCarried in blood by lipoproteins or specific binding proteins
StorageStored in liver and adipose tissue (not readily excreted)
ExcretionVia feces (bile)
DeficiencySlow to develop (due to body stores)
ToxicityHypervitaminosis possible (accumulation in tissues)

1.2 Water-Soluble Vitamins (B-Complex and Vitamin C)

PropertyCharacteristics
SolubilitySoluble in water
AbsorptionReadily absorbed from intestine
TransportFree in blood (not bound to proteins)
StorageMinimal storage (except vitamin B12); excess excreted
ExcretionVia urine (renal threshold varies)
DeficiencyDevelops rapidly (weeks to months)
ToxicityRare (excess excreted); exceptions: B6, niacin (high doses)

Summary of Vitamin Classification:

ClassVitaminsKey Features
Fat-solubleA, D, E, KRequire dietary fat for absorption; stored in liver/adipose; risk of toxicity
Water-solubleB1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folate), B12 (cobalamin), C (ascorbic acid)Not stored (except B12); excess excreted in urine; deficiency develops faster

2. Fat-Soluble Vitamins

2.1 Vitamin A (Retinoids)

Structure:

  • Vitamin A refers to a family of compounds with similar structure: retinol (alcohol), retinal (aldehyde), retinoic acid (acid), and retinyl esters (storage form).
  • β-Carotene (provitamin A) is cleaved in intestine to yield two molecules of retinal.

Natural Sources:

  • Preformed vitamin A (retinyl esters) : Liver, fish liver oils (cod liver oil), egg yolk, butter, whole milk, fortified dairy products
  • Provitamin A carotenoids (β-carotene, α-carotene, β-cryptoxanthin) : Dark green leafy vegetables (spinach, kale), orange and yellow vegetables (carrots, sweet potatoes, pumpkin), orange fruits (mango, papaya, apricots)

Synthetic Sources:

  • Retinyl palmitate, retinyl acetate (used in supplements and fortified foods)
  • Isotretinoin (13-cis-retinoic acid) for acne
  • Tretinoin (all-trans-retinoic acid) for acne and acute promyelocytic leukemia

Recommended Dietary Allowance (RDA) :

  • Adult men: 900 μg RAE (retinol activity equivalents)/day
  • Adult women: 700 μg RAE/day
  • 1 μg RAE = 1 μg retinol = 12 μg β-carotene = 24 μg other provitamin A carotenoids

Metabolic Functions:

FunctionMechanismActive Form
VisionComponent of rhodopsin (rod cells) and iodopsins (cone cells); cis-retinal isomerizes to trans-retinal upon light absorption, triggering nerve impulse11-cis-retinal
Gene expressionRetinoic acid binds to nuclear receptors (RAR, RXR) → regulate gene transcription (cell differentiation, proliferation, apoptosis)All-trans-retinoic acid, 9-cis-retinoic acid
Immune functionMaintains integrity of mucosal barriers; enhances lymphocyte functionRetinoic acid
Epithelial cell differentiationPrevents keratinization; maintains healthy skin, mucous membranesRetinoic acid
ReproductionSpermatogenesis in males; maintenance of pregnancy in femalesRetinol
Growth and developmentBone remodeling, embryonic developmentRetinoic acid

Physiological Role in Detail:

A. Visual Cycle:

  • In rod cells, 11-cis-retinal is bound to opsin protein forming rhodopsin.
  • Light absorption isomerizes 11-cis-retinal to all-trans-retinal → conformational change in opsin → activation of transducin (G protein) → signal cascade → nerve impulse.
  • All-trans-retinal is reduced to all-trans-retinol, transported to retinal pigment epithelium, re-isomerized to 11-cis-retinol, oxidized to 11-cis-retinal, and returned to rod cells.

B. Gene Regulation:

  • Retinoic acid enters nucleus, binds to retinoic acid receptors (RAR) and retinoid X receptors (RXR) as heterodimers.
  • These bind to retinoic acid response elements (RARE) in DNA, regulating transcription of genes involved in differentiation, development, and apoptosis.

Deficiency:

Deficiency StateClinical Features
Night blindness (nyctalopia)Earliest sign; difficulty seeing in dim light due to impaired rhodopsin regeneration
XerophthalmiaDryness of conjunctiva and cornea; progresses to Bitot's spots (foamy patches), corneal ulceration, keratomalacia (softening), blindness
Follicular hyperkeratosisDry, rough skin with follicular plugging (gooseflesh appearance)
Increased susceptibility to infectionsImpaired mucosal barriers and immune function
Impaired growthIn children

At-risk populations: Children in developing countries (leading cause of preventable blindness), malabsorption syndromes (celiac, Crohn's, cystic fibrosis, pancreatic insufficiency), chronic liver disease, alcoholism.

Toxicity (Hypervitaminosis A) :

TypeCauseClinical Features
Acute toxicitySingle massive dose (e.g., >200,000 μg in adults)Nausea, vomiting, headache, dizziness, blurred vision, increased intracranial pressure (mimics brain tumor)
Chronic toxicityExcessive intake over time (e.g., >30,000 μg/day for months)Dry skin, cheilitis (cracked lips), alopecia, bone pain, hepatomegaly, hyperlipidemia, teratogenicity (birth defects)
TeratogenicityHigh doses during pregnancyCranial-neural crest defects (craniofacial, cardiac, thymus abnormalities) – isotretinoin is contraindicated in pregnancy

Carotenemia: Excessive β-carotene intake causes yellow-orange skin discoloration (especially palms and soles); benign, reversible.

Pharmacological Interactions with Drugs:

DrugInteraction
Orlistat (weight loss)Reduces absorption of fat-soluble vitamins, including vitamin A
Mineral oil (laxative)Chronic use can dissolve vitamin A and reduce absorption
Neomycin, cholestyramineInterfere with fat absorption → reduced vitamin A absorption
Retinoids (isotretinoin, acitretin)Additive toxicity with vitamin A supplements (avoid concurrent use)
Oral contraceptivesMay increase serum retinol levels

Pharmaceutical Importance:

  • Treatment of vitamin A deficiency and xerophthalmia
  • Isotretinoin for severe nodular acne
  • Tretinoin (all-trans-retinoic acid) for acute promyelocytic leukemia (induces differentiation of leukemic cells)
  • Topical retinoids (tretinoin, adapalene) for acne and photoaging
  • β-Carotene supplements (controversial; may increase lung cancer risk in smokers)

2.2 Vitamin D (Calciferol)

Structure:

  • Vitamin D is a secosteroid (broken steroid ring). Two major forms:
    • Vitamin D₂ (ergocalciferol) : From plants, yeast (ergosterol irradiated with UV)
    • Vitamin D₃ (cholecalciferol) : Synthesized in skin from 7-dehydrocholesterol upon UVB exposure; also in animal sources

Natural Sources:

  • Dietary: Fatty fish (salmon, mackerel, sardines), fish liver oils, egg yolk, beef liver, cheese, UV-exposed mushrooms
  • Fortified foods: Milk, orange juice, cereals, margarine (in some countries)
  • Endogenous synthesis: Skin exposure to sunlight (UVB, 290-315 nm) converts 7-dehydrocholesterol to previtamin D₃, which isomerizes to vitamin D₃

Synthetic Sources:

  • Vitamin D₂ (ergocalciferol) and D₃ (cholecalciferol) supplements
  • Calcitriol (1,25-dihydroxyvitamin D₃) for renal failure patients
  • Calcipotriol (synthetic analog) for psoriasis

Recommended Dietary Allowance (RDA) :

  • Adults 19-70 years: 600 IU (15 μg)/day
  • Adults >70 years: 800 IU (20 μg)/day
  • Upper level: 4000 IU (100 μg)/day

Metabolic Activation:

7-Dehydrocholesterol (skin)
        │ UVB
        ↓
Vitamin D₃ (cholecalciferol) ──┐ (dietary vitamin D₂/D₃)
                               │
                               ↓
                   Liver (25-hydroxylase, CYP2R1)
                               ↓
               25-Hydroxyvitamin D [25(OH)D] (major circulating form)
                               │
                   Kidney (1α-hydroxylase, CYP27B1)
                    (stimulated by PTH, low Ca, low phosphate)
                               ↓
               1,25-Dihydroxyvitamin D [1,25(OH)₂D] (calcitriol) – active form
  • Renal 1α-hydroxylase is tightly regulated.
  • 24-Hydroxylase (CYP24A1) inactivates both 25(OH)D and 1,25(OH)₂D to calcitroic acid.

Metabolic Functions:

FunctionMechanism
Calcium homeostasisIncreases intestinal calcium absorption (via calbindin synthesis); promotes bone resorption (with PTH); enhances renal calcium reabsorption
Phosphate homeostasisIncreases intestinal phosphate absorption; promotes renal phosphate reabsorption (with PTH)
Bone mineralizationProvides adequate calcium and phosphate for hydroxyapatite deposition
Cell differentiation and proliferationRegulates gene expression via vitamin D receptor (VDR); promotes differentiation of keratinocytes, immune cells; inhibits proliferation of某些 cells
Immune modulationEnhances innate immunity (macrophage function); regulates adaptive immunity (suppresses Th1, promotes Treg)
Insulin secretionPancreatic β-cells express VDR; may influence insulin secretion

Physiological Role in Detail:

A. Calcium and Phosphate Homeostasis:

  • Intestine: 1,25(OH)₂D binds to VDR in enterocytes, increases expression of TRPV6 (calcium channel), calbindin (calcium-binding protein), and PMCA1b (calcium ATPase) → increased calcium absorption. Also increases phosphate absorption via NaPi-IIb.
  • Bone: 1,25(OH)₂D with PTH stimulates osteoclast differentiation (via RANKL on osteoblasts) → bone resorption → release of calcium and phosphate.
  • Kidney: Increases calcium reabsorption in distal tubules; increases phosphate reabsorption (but PTH opposes this, net effect increased phosphate excretion with high PTH).

B. Parathyroid Hormone (PTH) Regulation:

  • Low serum calcium → increased PTH → increased 1α-hydroxylase → increased 1,25(OH)₂D → increased calcium absorption and bone resorption.
  • 1,25(OH)₂D feeds back to inhibit PTH synthesis.

Deficiency:

ConditionClinical Features
Rickets (children)Impaired mineralization of growing bone: bowed legs, thickened wrists and ankles, rachitic rosary (beading of ribs), craniotabes (soft skull), delayed fontanelle closure, muscle weakness
Osteomalacia (adults)Demineralization of existing bone: bone pain (hips, lower back), muscle weakness, increased fracture risk, waddling gait
OsteoporosisLow vitamin D contributes to low bone mineral density
Increased infection riskImpaired innate immunity (macrophages produce antimicrobial peptides cathelicidin in response to vitamin D)
HypocalcemiaMay cause tetany, paresthesias, seizures (if severe)

At-risk populations: Elderly (reduced skin synthesis, dietary intake), dark-skinned individuals (melanin reduces UV synthesis), institutionalized/little sun exposure, malabsorption syndromes, obesity (sequestered in fat), chronic kidney disease (reduced 1α-hydroxylase), anticonvulsant therapy (increased catabolism).

Toxicity (Hypervitaminosis D) :

FeatureMechanism
HypercalcemiaIncreased intestinal calcium absorption and bone resorption
HypercalciuriaKidney stones, nephrocalcinosis
Soft tissue calcificationCalcium deposits in blood vessels, kidneys, heart, lungs
SymptomsNausea, vomiting, weakness, polyuria, polydipsia, constipation, confusion

Causes: Excessive supplementation (>10,000 IU/day for months); rarely from diet or sun exposure (synthesis is regulated).

Pharmacological Interactions with Drugs:

DrugInteraction
Thiazide diureticsReduce urinary calcium excretion; may cause hypercalcemia with high vitamin D
CorticosteroidsAntagonize vitamin D action; reduce calcium absorption
Anticonvulsants (phenytoin, phenobarbital)Induce CYP450 enzymes that increase vitamin D catabolism → deficiency
Orlistat, cholestyramineReduce absorption of fat-soluble vitamins
Calcium-containing supplementsAdditive effects on serum calcium
DigoxinHypercalcemia increases digoxin toxicity risk

Pharmaceutical Importance:

  • Treatment and prevention of vitamin D deficiency, rickets, osteomalacia
  • Calcium and vitamin D supplementation for osteoporosis (with bisphosphonates)
  • Calcitriol for hypocalcemia in chronic kidney disease (renal osteodystrophy)
  • Calcipotriol (topical) for psoriasis (regulates keratinocyte proliferation)
  • Vitamin D analogs (paricalcitol, doxercalciferol) for secondary hyperparathyroidism in CKD

2.3 Vitamin E (Tocopherols and Tocotrienols)

Structure:

  • Vitamin E refers to eight naturally occurring compounds: four tocopherols (α, β, γ, δ) and four tocotrienols.
  • α-Tocopherol is the most biologically active form (due to preference of α-tocopherol transfer protein in liver).

Natural Sources:

  • Vegetable oils (soybean, sunflower, corn, olive), nuts (almonds, peanuts), seeds (sunflower), wheat germ, green leafy vegetables, fortified cereals

Synthetic Sources:

  • All-rac-α-tocopherol (synthetic; half the activity of natural RRR-α-tocopherol)
  • Tocopheryl acetate, tocopheryl succinate (esterified forms for stability in supplements)

Recommended Dietary Allowance (RDA) :

  • Adults: 15 mg (22.4 IU) of α-tocopherol/day
  • Upper level: 1000 mg/day (from supplements; toxicity risk)

Metabolic Functions:

FunctionMechanism
AntioxidantProtects polyunsaturated fatty acids (PUFA) in membranes and lipoproteins from lipid peroxidation; breaks chain reaction by donating hydrogen to peroxyl radical; becomes tocopheroxyl radical (regenerated by vitamin C, glutathione)
Membrane stabilityMaintains membrane fluidity and integrity
Cell signalingModulates activity of protein kinase C, phospholipase A₂, cyclooxygenase; affects gene expression (via regulation of transcription factors)
Immune functionEnhances T-lymphocyte function, especially in elderly
Inhibition of platelet aggregationReduces platelet adhesion and aggregation (antithrombotic effect)

Physiological Role in Detail:

A. Antioxidant Mechanism:

  • Lipid peroxidation is a chain reaction: initiation (ROS abstracts H from PUFA) → lipid radical → reacts with O₂ → lipid peroxyl radical → abstracts H from another PUFA, propagating chain.
  • Vitamin E (α-tocopherol) donates H to lipid peroxyl radical, forming lipid hydroperoxide and tocopheroxyl radical.
  • Tocopheroxyl radical is relatively stable and can be reduced back to tocopherol by vitamin C (ascorbate) or glutathione.

B. Protection of LDL:

  • Vitamin E in LDL particles prevents oxidative modification of LDL, which is implicated in atherosclerosis.

Deficiency:

ConditionClinical Features
Peripheral neuropathyAxonal degeneration, especially sensory nerves; areflexia, ataxia, loss of vibration/position sense
MyopathyMuscle weakness, elevated creatine kinase
Hemolytic anemiaIn premature infants (RBC membranes fragile due to low vitamin E)
RetinopathyPigmentary changes, vision loss (in severe deficiency)
Impaired immune functionIncreased susceptibility to infections

Causes: Severe malabsorption (cystic fibrosis, cholestasis, abetalipoproteinemia – defect in lipoprotein assembly, leading to vitamin E malabsorption), genetic defects in α-tocopherol transfer protein (ataxia with isolated vitamin E deficiency, AVED).

At-risk populations: Premature infants (low stores, rapid growth), malabsorption syndromes, abetalipoproteinemia.

Toxicity (Hypervitaminosis E) :

  • Relatively low toxicity compared to A and D.
  • High doses (>1000 mg/day) may:
    • Increase bleeding risk (antagonizes vitamin K, inhibits platelet aggregation)
    • Interfere with vitamin K metabolism (enhances anticoagulant effect of warfarin)
    • Nausea, diarrhea, headache, fatigue (rare)

Pharmacological Interactions with Drugs:

DrugInteraction
Warfarin, anticoagulantsVitamin E may potentiate anticoagulant effect (↑ bleeding risk)
Antiplatelet drugs (aspirin, clopidogrel)Additive antiplatelet effect
Vitamin KVitamin E may antagonize vitamin K (affects clotting factor synthesis)
CyclosporineVitamin E may increase cyclosporine absorption (in some formulations)
Orlistat, cholestyramineReduce vitamin E absorption

Pharmaceutical Importance:

  • Treatment of vitamin E deficiency (especially in malabsorption, AVED)
  • Antioxidant in formulations (protects labile drugs)
  • Topical preparations for skin protection
  • Supplements for cardiovascular health (controversial efficacy; meta-analyses show no clear benefit)
  • Used in some neurological disorders (tardive dyskinesia, Alzheimer's – limited evidence)

2.4 Vitamin K (Phylloquinone, Menaquinones, Menadione)

Structure:

  • Vitamin K₁ (phylloquinone) : From plants; contains phytyl side chain
  • Vitamin K₂ (menaquinones) : From bacteria (gut flora); multiple forms (MK-4 to MK-13) with varying isoprenoid side chains; MK-4 also synthesized from K₁ in some tissues
  • Vitamin K₃ (menadione) : Synthetic, water-soluble prodrug (alkylated to menaquinone-4 in vivo)

Natural Sources:

  • Vitamin K₁: Green leafy vegetables (spinach, kale, broccoli, Brussels sprouts), vegetable oils (soybean, canola)
  • Vitamin K₂: Fermented foods (natto – rich in MK-7), cheese, egg yolk, meat; also synthesized by gut bacteria (but contribution to human needs is debated)

Synthetic Sources:

  • Menadione (vitamin K₃) – used in animal feed; not recommended for humans (toxicity risk)
  • Phytonadione (vitamin K₁) for human supplements and injection

Recommended Dietary Allowance (RDA) :

  • Adult men: 120 μg/day
  • Adult women: 90 μg/day
  • Adequate intake (AI) rather than RDA, as deficiency is rare except in specific conditions

Metabolic Functions:

FunctionMechanism
Blood coagulationCofactor for γ-glutamyl carboxylase, which converts specific glutamate (Glu) residues to γ-carboxyglutamate (Gla) in clotting factors II (prothrombin), VII, IX, X, and proteins C, S, Z
Bone metabolismCarboxylation of osteocalcin (bone Gla protein) and matrix Gla protein (MGP); enables calcium binding and bone mineralization
Vascular healthMGP inhibits vascular calcification; undercarboxylated MGP associated with arterial calcification
Cell growth and apoptosisSome Gla proteins involved in signal transduction, cell cycle regulation

Physiological Role in Detail:

A. Blood Coagulation Cascade:

  • Clotting factors are synthesized in liver as inactive precursors.
  • Vitamin K-dependent γ-carboxylation adds a second carboxyl group to specific Glu residues → Gla residues bind calcium → factors can bind to phospholipid surfaces (platelet membranes) and participate in coagulation complexes.
  • Without carboxylation, factors are inactive (PIVKA – proteins induced by vitamin K absence).
  • Warfarin anticoagulants inhibit vitamin K epoxide reductase (VKOR), preventing recycling of vitamin K.

B. Bone Metabolism:

  • Osteocalcin: Synthesized by osteoblasts; γ-carboxylated osteocalcin binds calcium and hydroxyapatite, regulating bone mineralization. Undercarboxylated osteocalcin may act as hormone (increases insulin secretion, testosterone production).
  • Matrix Gla protein (MGP) : Inhibits vascular calcification; requires vitamin K-dependent carboxylation for activity.

C. Vitamin K Cycle:

Vitamin K (quinone)
      │ (NAD(P)H-dependent reductase, also sensitive to warfarin)
      ↓
Vitamin K hydroquinone (active cofactor for γ-glutamyl carboxylase)
      │ (carboxylates Glu to Gla)
      ↓
Vitamin K epoxide
      │ (vitamin K epoxide reductase, VKOR – warfarin-sensitive)
      └───────────────────┘

Deficiency:

ConditionClinical Features
Hemorrhagic disease of newbornBleeding in first week of life (classic) or 2-12 weeks (late) due to low vitamin K stores, sterile gut, low breast milk content
Coagulopathy in adultsEasy bruising, ecchymosis, bleeding (gums, nose, GI), prolonged prothrombin time (PT), increased INR
Bone abnormalitiesLow bone mineral density, increased fracture risk (undercarboxylated osteocalcin)
Vascular calcificationIn deficiency of MGP carboxylation (animal models; human data suggestive)

Causes: Newborns (prophylactic vitamin K given), malabsorption (celiac, cystic fibrosis, short bowel, biliary obstruction), chronic liver disease, long-term antibiotic use (reduces gut flora – though contribution of gut K₂ is debated), anticoagulant therapy (warfarin), nutritional deficiency (rare in adults due to wide distribution).

Toxicity (Hypervitaminosis K) :

  • Vitamin K₁ and K₂: No known toxicity; excess excreted.
  • Menadione (K₃) : Can cause hemolytic anemia, jaundice (oxidative stress), especially in G6PD deficiency; not used in humans.

Pharmacological Interactions with Drugs:

DrugInteraction
WarfarinVitamin K antagonizes warfarin effect (reverses anticoagulation) – used as antidote for warfarin overdose
Antibiotics (broad-spectrum)May reduce vitamin K production by gut flora (but clinical significance debated); risk higher with poor dietary intake
Orlistat, cholestyramineReduce absorption of fat-soluble vitamins
Cephalosporins (certain, e.g., cefamandole, cefoperazone)Contain N-methylthiotetrazole side chain that inhibits vitamin K epoxide reductase → hypoprothrombinemia
Anticonvulsants (phenytoin, phenobarbital)May increase vitamin K catabolism; newborns of mothers on these drugs may have increased bleeding risk

Pharmaceutical Importance:

  • Prevention and treatment of vitamin K deficiency bleeding (VKDB) in newborns (intramuscular vitamin K₁ at birth)
  • Reversal of warfarin overdose (oral or intravenous vitamin K₁)
  • Treatment of coagulopathy due to malabsorption, liver disease, or antibiotic use
  • Phytonadione injection for hemorrhagic disease
  • Potential role in bone health and vascular calcification (under investigation)

3. Water-Soluble Vitamins

3.1 Vitamin B₁ (Thiamine)

Structure: Thiamine consists of a pyrimidine ring and a thiazole ring linked by a methylene bridge. It is phosphorylated to thiamine pyrophosphate (TPP), the active coenzyme form.

Natural Sources: Pork, whole grains, legumes, nuts, seeds, yeast, fortified cereals, brown rice

Synthetic Sources: Thiamine hydrochloride, thiamine mononitrate (in supplements and fortified foods)

Recommended Dietary Allowance (RDA) :

  • Adult men: 1.2 mg/day
  • Adult women: 1.1 mg/day

Metabolic Functions (as TPP) :

FunctionMechanism
Carbohydrate metabolismCoenzyme for pyruvate dehydrogenase (pyruvate → acetyl-CoA) and α-ketoglutarate dehydrogenase (TCA cycle)
Pentose phosphate pathwayCoenzyme for transketolase (links PPP to glycolysis)
Branched-chain amino acid metabolismCoenzyme for branched-chain α-ketoacid dehydrogenase
Nerve functionRole in neurotransmitter synthesis (acetylcholine) and nerve membrane function

Physiological Role:

  • TPP is essential for oxidative decarboxylation of α-ketoacids.
  • Transketolase in PPP generates NADPH and pentoses for nucleotide synthesis.
  • Thiamine triphosphate (TTP) may have role in nerve conduction.

Deficiency (Beriberi) :

TypeClinical Features
Dry beriberiPeripheral neuropathy (symmetrical motor and sensory), muscle wasting, areflexia, paresthesias, difficulty walking
Wet beriberiHigh-output cardiac failure (dilated cardiomyopathy, edema, tachycardia, dyspnea), due to impaired energy metabolism in heart
Infantile beriberiIn breastfed infants of thiamine-deficient mothers; acute cardiac failure, aphonia, vomiting
Wernicke-Korsakoff syndrome (in alcoholics)Wernicke encephalopathy: confusion, ataxia, ophthalmoplegia, nystagmus; Korsakoff psychosis: memory impairment, confabulation (irreversible)

Causes: Alcoholism (most common in developed countries; impaired absorption, storage, and phosphorylation), polished rice diet (in developing countries), hyperemesis gravidarum, malabsorption, bariatric surgery, chronic dialysis.

Pharmacological Interactions with Drugs:

DrugInteraction
Loop diuretics (furosemide)Increase urinary thiamine loss
DigoxinMay increase thiamine excretion
AlcoholImpairs thiamine absorption and utilization
5-FluorouracilMay cause thiamine deficiency (interferes with TPP synthesis)

Pharmaceutical Importance:

  • Treatment of beriberi and Wernicke-Korsakoff syndrome (high-dose thiamine IV/IM before glucose infusion to prevent acute deficiency)
  • Supplementation in alcoholics, malabsorption, bariatric surgery patients
  • Fortification of foods

3.2 Vitamin B₂ (Riboflavin)

Structure: Riboflavin consists of isoalloxazine ring (yellow) attached to ribitol (sugar alcohol). Active coenzyme forms: flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD).

Natural Sources: Milk and dairy products, eggs, meat (liver), green leafy vegetables, almonds, fortified cereals

Synthetic Sources: Riboflavin supplements; riboflavin-5'-phosphate (FMN) for injection

Recommended Dietary Allowance (RDA) :

  • Adult men: 1.3 mg/day
  • Adult women: 1.1 mg/day

Metabolic Functions (as FMN/FAD) :

FunctionMechanism
Electron transport chainFAD in complex II (succinate dehydrogenase); FMN in complex I
Fatty acid oxidationAcyl-CoA dehydrogenase (FAD)
TCA cycleSuccinate dehydrogenase (FAD), α-ketoglutarate dehydrogenase (FAD)
Redox reactionsMany dehydrogenases, oxidases, reductases use FAD/FMN
AntioxidantGlutathione reductase (FAD) regenerates GSH; thioredoxin reductase (FAD)

Physiological Role:

  • FAD and FMN are prosthetic groups for numerous oxidoreductases involved in energy production, detoxification, and biosynthesis.
  • Riboflavin is also involved in vitamin B₆ activation and niacin formation from tryptophan.

Deficiency (Ariboflavinosis) :

Clinical Features
Cheilosis (fissures at angles of mouth)
Angular stomatitis
Glossitis (magenta tongue)
Seborrheic dermatitis (nasolabial folds, scrotum, vulva)
Corneal vascularization, photophobia
Normochromic normocytic anemia

Causes: Poor diet (alcoholism, elderly), malabsorption, phototherapy for neonatal jaundice (light degrades riboflavin), chronic use of certain drugs.

Pharmacological Interactions with Drugs:

DrugInteraction
Chlorpromazine, tricyclic antidepressantsInhibit riboflavin phosphorylation
ProbenecidReduces riboflavin absorption
Oral contraceptivesMay increase riboflavin requirement
PhenobarbitalMay increase riboflavin metabolism

Pharmaceutical Importance:

  • Treatment of ariboflavinosis
  • Part of multivitamin supplements
  • Used in phototherapy for neonatal jaundice (riboflavin as photosensitizer – experimental)

3.3 Vitamin B₃ (Niacin, Nicotinic Acid, Nicotinamide)

Structure: Niacin refers to both nicotinic acid (pyridine-3-carboxylic acid) and nicotinamide (niacinamide). Active coenzyme forms: NAD⁺ (nicotinamide adenine dinucleotide) and NADP⁺ (nicotinamide adenine dinucleotide phosphate).

Natural Sources: Meat (liver, chicken, fish), poultry, peanuts, legumes, whole grains, fortified cereals; also synthesized from tryptophan (60 mg tryptophan → 1 mg niacin)

Synthetic Sources: Nicotinic acid, nicotinamide in supplements; extended-release formulations for dyslipidemia

Recommended Dietary Allowance (RDA) :

  • Adult men: 16 mg NE (niacin equivalents)/day
  • Adult women: 14 mg NE/day

Metabolic Functions (as NAD⁺/NADP⁺) :

FunctionMechanism
Redox reactionsNAD⁺/NADH in catabolic pathways (glycolysis, TCA, β-oxidation); NADP⁺/NADPH in anabolic pathways (fatty acid synthesis, cholesterol synthesis) and antioxidant defense (glutathione reductase)
ADP-ribosylationNAD⁺ donates ADP-ribose for protein modification (PARP enzymes – DNA repair, stress response)
Sirtuin activationNAD⁺-dependent deacetylases (sirtuins) regulate aging, metabolism, stress resistance
Second messengerNAD⁺ converted to cyclic ADP-ribose (cADPR) and NAADP, involved in calcium signaling

Physiological Role:

  • NAD⁺ is essential for hundreds of redox reactions.
  • NADPH is crucial for reductive biosynthesis and antioxidant defense.
  • Poly(ADP-ribose) polymerase (PARP) uses NAD⁺ for DNA repair; excessive activation depletes NAD⁺ and ATP (cell death).

Deficiency (Pellagra) :

FeatureDescription
DermatitisSymmetrical, photosensitive rash on sun-exposed areas (Casal's necklace – around neck)
DiarrheaInflammation of GI mucosa
DementiaConfusion, memory loss, depression, psychosis
DeathIf untreated (fourth D)

Causes: Corn-based diets (niacin in corn is bound and unavailable; tryptophan low), alcoholism, carcinoid syndrome (tryptophan diverted to serotonin), Hartnup disease (tryptophan malabsorption), isoniazid therapy (competes with tryptophan)

Pharmacological Uses of Niacin:

UseMechanismDose
DyslipidemiaInhibits lipolysis in adipose tissue → reduces VLDL synthesis; increases HDL (via decreased catabolism)1-3 g/day (nicotinic acid, not nicotinamide)
Side effectsFlushing (prostaglandin-mediated), hepatotoxicity, hyperglycemia, hyperuricemiaAspirin pretreatment reduces flushing

Pharmacological Interactions with Drugs:

DrugInteraction
StatinsIncreased risk of myopathy (especially with high-dose niacin)
Antidiabetic drugsNiacin may worsen glycemic control
AlcoholMay exacerbate niacin-induced hepatotoxicity
AnticoagulantsNiacin may increase bleeding risk (minimal)

Pharmaceutical Importance:

  • Treatment and prevention of pellagra
  • Nicotinic acid (niacin) for dyslipidemia (prescription formulations)
  • Nicotinamide in multivitamins (no flushing effect)
  • Topical nicotinamide for acne (anti-inflammatory)
  • NAD⁺ precursors (nicotinamide riboside, NMN) as anti-aging supplements (experimental)

3.4 Vitamin B₅ (Pantothenic Acid)

Structure: Pantothenic acid consists of pantoic acid linked to β-alanine. Active coenzyme form: Coenzyme A (CoA) and acyl carrier protein (ACP).

Natural Sources: Widely distributed in foods: meat (liver), chicken, egg yolk, whole grains, legumes, avocados, broccoli, mushrooms ("pantothen" means "from everywhere")

Synthetic Sources: Calcium pantothenate, panthenol (provitamin used in topical products)

Recommended Dietary Allowance (RDA) :

  • Adults: 5 mg/day (adequate intake)

Metabolic Functions (as CoA) :

FunctionMechanism
Fatty acid metabolismActivation of fatty acids (acyl-CoA) for β-oxidation or synthesis
TCA cycleAcetyl-CoA enters TCA; succinyl-CoA in TCA step
Cholesterol synthesisHMG-CoA intermediate
Neurotransmitter synthesisAcetylcholine synthesis (acetyl-CoA + choline)
Heme synthesisSuccinyl-CoA + glycine → ALA
Acyl carrier proteinPart of fatty acid synthase complex; carries growing acyl chain

Physiological Role:

  • CoA is essential for acyl transfer reactions.
  • ACP is integral to fatty acid synthesis.

Deficiency:

  • Extremely rare due to wide distribution.
  • Experimental deficiency (with antagonist) causes: fatigue, headache, paresthesias (burning feet syndrome), insomnia, nausea, abdominal cramps, hypoglycemia.

Causes: Severe malnutrition, alcoholism (may contribute to "burning feet syndrome").

Pharmaceutical Importance:

  • Part of multivitamin supplements
  • Panthenol in topical preparations (wound healing, moisturizer) – converted to pantothenic acid in skin
  • Calcium pantothenate in hair and skin products

3.5 Vitamin B₆ (Pyridoxine, Pyridoxal, Pyridoxamine)

Structure: Three naturally occurring forms: pyridoxine (alcohol), pyridoxal (aldehyde), pyridoxamine (amine). All are converted to active coenzyme: pyridoxal-5'-phosphate (PLP).

Natural Sources: Meat (liver, poultry), fish, potatoes, bananas, chickpeas, nuts, whole grains, fortified cereals

Synthetic Sources: Pyridoxine hydrochloride (most common supplement form)

Recommended Dietary Allowance (RDA) :

  • Adults 19-50 years: 1.3 mg/day
  • Older adults: 1.5-1.7 mg/day

Metabolic Functions (as PLP) :

FunctionMechanism
Amino acid metabolismTransamination (aminotransferases), deamination, decarboxylation, racemization
Neurotransmitter synthesisDecarboxylation: glutamate → GABA; DOPA → dopamine; 5-HTP → serotonin; histidine → histamine
Heme synthesisALA synthase (glycine + succinyl-CoA) requires PLP
GlycogenolysisGlycogen phosphorylase has PLP as prosthetic group
Sphingolipid synthesisSerine palmitoyltransferase
Niacin synthesisKynureninase in tryptophan → niacin pathway
Homocysteine metabolismCystathionine β-synthase (homocysteine → cystathionine) requires PLP

Physiological Role:

  • PLP is cofactor for >140 enzymes, primarily in amino acid metabolism.
  • Essential for neurotransmitter balance, heme production, and one-carbon metabolism.

Deficiency:

Clinical Features
Seborrheic dermatitis (around eyes, nose, mouth)
Glossitis, cheilosis
Microcytic hypochromic anemia (due to impaired heme synthesis)
Peripheral neuropathy (sensory)
Confusion, depression, irritability (impaired neurotransmitter synthesis)
Electroencephalogram (EEG) abnormalities, seizures (in infants)

Causes: Alcoholism (acetaldehyde displaces PLP), isoniazid, hydralazine, penicillamine (form hydrazones with PLP, inactivate it), oral contraceptives (may increase requirement), malabsorption, chronic kidney disease (increased PLP loss in dialysis)

Pharmacological Interactions with Drugs:

DrugInteraction
Isoniazid (INH)INH forms hydrazone with PLP, inactivating it; causes peripheral neuropathy – prevented by pyridoxine supplementation (25-50 mg/day)
LevodopaPyridoxine enhances peripheral decarboxylation of levodopa to dopamine (reduces CNS levels); but with carbidopa, pyridoxine safe
CycloserineAntagonist of PLP
HydralazineForms hydrazone with PLP
TheophyllineMay increase pyridoxine requirement (seizure threshold)

Toxicity (from supplements) :

FeatureMechanism
Sensory neuropathyAt doses >200 mg/day long-term; gait disturbance, numbness, loss of proprioception
Dermatitis, photosensitivityRare

Pharmaceutical Importance:

  • Treatment and prevention of B₆ deficiency (isoniazid therapy, alcoholism)
  • Management of homocystinuria (high-dose B₆ responsive forms)
  • Treatment of sideroblastic anemia (some forms respond to B₆)
  • Premenstrual syndrome (controversial, low-dose)
  • Nausea in pregnancy (pyridoxine with doxylamine – Diclegis)

3.6 Vitamin B₇ (Biotin)

Structure: Biotin is a ureido ring fused with a tetrahydrothiophene ring with a valeric acid side chain.

Natural Sources: Liver, egg yolk (but raw egg white contains avidin, which binds biotin and prevents absorption), nuts, seeds, legumes, mushrooms, bananas, cauliflower

Synthetic Sources: D-biotin in supplements

Recommended Dietary Allowance (RDA) :

  • Adults: 30 μg/day (adequate intake)

Metabolic Functions:

FunctionMechanism
Carboxylation reactionsCofactor for carboxylases: acetyl-CoA carboxylase (fatty acid synthesis), pyruvate carboxylase (gluconeogenesis), propionyl-CoA carboxylase (odd-chain fatty acid metabolism), methylcrotonyl-CoA carboxylase (leucine metabolism)
Biotinylation of histonesEpigenetic regulation of gene expression
Cell signalingGuanylate cyclase activation? (Less defined)

Mechanism:

  • Biotin is covalently bound to carboxylases via amide linkage to lysine (biocytin).
  • It carries activated CO₂ as carboxybiotin, transferring it to substrates.

Deficiency:

Clinical Features
Dermatitis (scaly, red rash around eyes, nose, mouth)
Conjunctivitis
Alopecia (hair loss)
Glossitis
Neurological symptoms (depression, lethargy, hallucinations, paresthesias)
Metabolic acidosis (due to impaired carboxylase function)

Causes: Raw egg white consumption (avidin), long-term parenteral nutrition without biotin, malabsorption, biotinidase deficiency (genetic disorder impairs biotin recycling), anticonvulsant therapy.

Pharmacological Interactions with Drugs:

DrugInteraction
Anticonvulsants (phenytoin, carbamazepine, phenobarbital)May accelerate biotin catabolism; increase biotin requirement
Antibiotics (long-term)May reduce gut flora synthesis (though contribution minimal)
Valproic acidMay inhibit biotinidase

Pharmaceutical Importance:

  • Treatment of biotin deficiency and biotinidase deficiency (high-dose biotin, 5-20 mg/day)
  • Supplements for hair, skin, nails (limited evidence)
  • Multiple carboxylase deficiency (biotin-responsive)

3.7 Vitamin B₉ (Folate, Folic Acid)

Structure: Folate consists of pteridine ring, p-aminobenzoic acid (PABA), and glutamic acid (usually polyglutamate in food). Folic acid (pteroylmonoglutamic acid) is the synthetic form used in supplements and fortified foods.

Natural Sources: Dark green leafy vegetables (spinach, kale), legumes (beans, lentils), liver, asparagus, Brussels sprouts, oranges, fortified grains and cereals

Synthetic Sources: Folic acid (pteroylmonoglutamic acid); folinic acid (5-formyltetrahydrofolate, leucovorin) for rescue after methotrexate

Recommended Dietary Allowance (RDA) :

  • Adults: 400 μg DFE (dietary folate equivalents)/day
  • Pregnancy: 600 μg DFE/day
  • Lactation: 500 μg DFE/day
  • 1 μg DFE = 1 μg food folate = 0.6 μg folic acid with food = 0.5 μg folic acid on empty stomach

Metabolic Functions:

FunctionMechanism
One-carbon transferTetrahydrofolate (THF) accepts and donates one-carbon units (methyl, methylene, formyl, formimino) for biosynthesis
Nucleotide synthesisPurine synthesis: glycineamide ribonucleotide (GAR) and aminoimidazole carboxamide ribonucleotide (AICAR) formyltransferases require 10-formyl-THF; pyrimidine synthesis: dTMP from dUMP requires 5,10-methylene-THF and thymidylate synthase
Amino acid metabolismConversion of homocysteine to methionine (methionine synthase) requires 5-methyl-THF and vitamin B12; serine to glycine (serine hydroxymethyltransferase)
Histidine catabolismFormiminoglutamate (FIGLU) transferase

Physiological Role:

  • Folate is essential for DNA synthesis, repair, and methylation.
  • Rapidly dividing cells (bone marrow, intestinal epithelium, fetus) have high folate requirement.
  • Folate deficiency causes megaloblastic anemia (impaired DNA synthesis → large, immature RBC precursors).

Folate Cycle and Methionine Synthase:

                    Homocysteine
                         │ (methionine synthase, requires B12, 5-methyl-THF)
                         ↓
                    Methionine
                         │ (ATP)
                         ↓
                    S-Adenosylmethionine (SAM) – universal methyl donor
                         ↓ (methyltransferase reactions)
                    S-Adenosylhomocysteine (SAH)
                         ↓
                    Homocysteine (regenerated)

Deficiency:

Clinical Features
Megaloblastic anemia (macrocytic RBCs, hypersegmented neutrophils)
Glossitis (smooth, red tongue)
Fatigue, weakness
Neural tube defects (NTD) in pregnancy (spina bifida, anencephaly)
Elevated homocysteine (cardiovascular risk factor)
Diarrhea, depression, irritability

Causes: Poor dietary intake (alcoholism, elderly, poverty), increased requirement (pregnancy, lactation, hemolytic anemias), malabsorption (celiac, Crohn's, atrophic gastritis), drugs (methotrexate, phenytoin, sulfasalazine, trimethoprim), alcohol (impairs absorption and metabolism)

Pharmacological Interactions with Drugs:

DrugInteraction
MethotrexateInhibits dihydrofolate reductase (DHFR), depletes reduced folate; leucovorin (folinic acid) rescue given after high-dose methotrexate
Trimethoprim, pyrimethamineInhibit DHFR (weaker in humans) – may exacerbate folate deficiency
Phenytoin, carbamazepine, phenobarbitalIncrease folate catabolism; may lower folate levels; folate supplements may decrease anticonvulsant efficacy (controversial)
SulfasalazineInhibits folate absorption and metabolism
Oral contraceptivesMay lower folate levels (clinical significance debated)
AlcoholImpairs folate absorption and increases excretion

Pharmaceutical Importance:

  • Prevention of neural tube defects (folic acid supplementation before and during early pregnancy) – 400-800 μg/day
  • Treatment of folate deficiency anemia (1 mg/day folic acid)
  • Adjunct to methotrexate therapy (leucovorin rescue)
  • Fortification of grains (in many countries) to reduce NTD risk
  • Management of hyperhomocysteinemia (with B12 and B6)
  • Folate antagonists (methotrexate) for cancer, autoimmune diseases

3.8 Vitamin B₁₂ (Cobalamin)

Structure: Complex corrin ring with central cobalt atom. Forms: cyanocobalamin (synthetic, stable), hydroxocobalamin, methylcobalamin, adenosylcobalamin (active coenzymes).

Natural Sources: Only from animal products: meat (liver), fish (shellfish), eggs, milk and dairy products; not found in plants (vegans at risk)

Synthetic Sources: Cyanocobalamin, hydroxocobalamin, methylcobalamin in supplements; hydroxocobalamin injection

Recommended Dietary Allowance (RDA) :

  • Adults: 2.4 μg/day
  • Pregnancy: 2.6 μg/day
  • Lactation: 2.8 μg/day

Absorption:

  1. Food B₁₂ bound to protein – released by gastric acid and pepsin.
  2. Binds to R-protein (haptocorrin) from saliva.
  3. In duodenum, pancreatic proteases degrade R-protein; B₁₂ binds to intrinsic factor (IF) from gastric parietal cells.
  4. IF-B₁₂ complex binds to cubam receptor (cubilin/amnionless) in ileum → endocytosis.
  5. In enterocyte, B₁₂ released, bound to transcobalamin II (TCII), enters portal blood.

Metabolic Functions:

FunctionMechanism
Methylmalonyl-CoA mutaseConverts methylmalonyl-CoA to succinyl-CoA (odd-chain fatty acid and branched-chain amino acid metabolism); requires adenosylcobalamin
Methionine synthaseRemethylates homocysteine to methionine (using 5-methyl-THF); requires methylcobalamin; links folate and B12 metabolism

Physiological Role:

  • Methylmalonyl-CoA mutase: Deficiency leads to methylmalonic aciduria (elevated methylmalonic acid in urine and plasma) – clinical marker of B12 deficiency.
  • Methionine synthase: Traps folate as 5-methyl-THF (methylfolate trap hypothesis) – B12 deficiency causes functional folate deficiency (megaloblastic anemia) despite normal folate levels.

Deficiency:

Clinical Features
Megaloblastic anemia (identical to folate deficiency)
Neurological symptoms (distinguishes from folate deficiency): Peripheral neuropathy (paresthesias, numbness), subacute combined degeneration of spinal cord (dorsal column – loss of vibration/position sense; corticospinal tract – spasticity, hyperreflexia), ataxia, cognitive impairment, dementia
Glossitis (smooth, red tongue)
Elevated homocysteine and methylmalonic acid

Causes: Pernicious anemia (autoimmune destruction of gastric parietal cells → lack of intrinsic factor), gastrectomy, ileal resection or disease (Crohn's), vegan diet (no animal products), chronic proton pump inhibitor use (reduced acid release), metformin (reduces calcium-dependent absorption), nitrous oxide (oxidizes cobalt, inactivates B12), tropical sprue, fish tapeworm (Diphyllobothrium latum)

Pernicious Anemia:

  • Autoimmune gastritis → antibodies against parietal cells or intrinsic factor.
  • Achlorhydria, low IF → B12 malabsorption.
  • Associated with other autoimmune diseases (thyroid, vitiligo).
  • Treatment: lifelong intramuscular B12 (or high-dose oral B12, as some passive absorption occurs).

Pharmacological Interactions with Drugs:

DrugInteraction
MetforminReduces calcium-dependent B12 absorption; long-term use may cause deficiency
Proton pump inhibitors, H₂ blockersReduce gastric acid, impair release of B12 from food (not affect IF-B12 absorption)
Nitrous oxide (N₂O)Oxidizes cobalt, inactivates B12; can cause acute neurological deterioration in at-risk patients
Colchicine, neomycinMay impair B12 absorption
CholestyramineBinds IF-B12 complex? May reduce absorption

Pharmaceutical Importance:

  • Treatment of pernicious anemia and B12 deficiency (IM hydroxocobalamin or cyanocobalamin; high-dose oral for mild deficiency)
  • Hydroxocobalamin as antidote for cyanide poisoning (binds cyanide)
  • Methylcobalamin supplements for neuropathy (popular in some countries)
  • Screening and management of B12 deficiency in at-risk populations (vegans, elderly, metformin users, post-gastrectomy)

3.9 Vitamin C (Ascorbic Acid)

Structure: Ascorbic acid is a six-carbon lactone with an enediol structure (reducing agent). Dehydroascorbic acid is the oxidized form (still active, can be reduced back).

Natural Sources: Citrus fruits (oranges, lemons), strawberries, kiwi, bell peppers, broccoli, tomatoes, potatoes

Synthetic Sources: Ascorbic acid, sodium ascorbate, calcium ascorbate, ascorbyl palmitate (fat-soluble ester) in supplements; added to foods as preservative (antioxidant)

Recommended Dietary Allowance (RDA) :

  • Adult men: 90 mg/day
  • Adult women: 75 mg/day
  • Smokers: +35 mg/day (increased oxidative stress)
  • Upper level: 2000 mg/day (to avoid GI distress)

Metabolic Functions:

FunctionMechanism
Collagen synthesisCofactor for prolyl hydroxylase and lysyl hydroxylase (hydroxylate proline and lysine in procollagen); essential for triple helix stability
AntioxidantScavenges ROS (hydroxyl radical, superoxide, singlet oxygen); regenerates vitamin E from tocopheroxyl radical
Carnitine synthesisCofactor for two hydroxylases in carnitine biosynthesis (from lysine and methionine)
Neurotransmitter synthesisCofactor for dopamine β-hydroxylase (dopamine → norepinephrine)
Tyrosine metabolismCofactor for p-hydroxyphenylpyruvate hydroxylase
Hormone synthesisPeptide hormone amidation (e.g., oxytocin, vasopressin) requires ascorbate
Iron absorptionEnhances intestinal iron absorption by reducing Fe³⁺ to Fe²⁺
Gene expressionModulates transcription factors (HIF-1α) – promotes hydroxylation, leading to HIF degradation

Physiological Role:

  • Collagen: Hydroxyproline and hydroxylysine are essential for collagen triple helix formation and cross-linking. Deficiency impairs wound healing, blood vessel integrity.
  • Antioxidant: Vitamin C is a major aqueous-phase antioxidant; protects lipids, proteins, DNA from oxidative damage.
  • Iron: Maintains iron in ferrous state for absorption and utilization.

Deficiency (Scurvy) :

Clinical FeaturesMechanism
Fatigue, malaiseImpaired carnitine synthesis (fatigue)
Perifollicular hemorrhagesFragile capillaries (poor collagen)
Petechiae, ecchymosisBleeding into skin
Gingival swelling, bleeding gumsDefective collagen in gums
Poor wound healingCollagen synthesis impaired
Joint pain, hemarthrosisBleeding into joints
Corkscrew hairsFollicular hyperkeratosis with hemorrhages
AnemiaBlood loss, impaired iron absorption

Causes: Poor diet (elderly, alcoholics, food insecurity), malabsorption, dialysis, smoking (increased turnover), pregnancy/lactation (increased requirement).

Pharmacological Interactions with Drugs:

DrugInteraction
Iron supplementsVitamin C enhances iron absorption
DeferoxamineVitamin C may increase iron mobilization and toxicity (in iron overload)
WarfarinHigh-dose vitamin C may interfere with INR (rare)
Aspirin, NSAIDsMay increase vitamin C requirement (increased excretion); high-dose vitamin C may irritate GI tract
EstrogensMay increase vitamin C requirement (increased metabolism)
Chemotherapy drugsConcern that high-dose vitamin C may interfere (antioxidant effects); evidence unclear

Toxicity (from high doses) :

FeatureMechanism
Diarrhea, nausea, abdominal crampsOsmotic diarrhea (unabsorbed vitamin C)
Kidney stonesIncreased oxalate excretion (ascorbic acid metabolized to oxalate); risk in predisposed individuals
Iron overloadIn hemochromatosis, enhances iron absorption

Pharmaceutical Importance:

  • Treatment and prevention of scurvy
  • Antioxidant in formulations (prevents oxidation of labile drugs)
  • Wound healing (topical or systemic, limited evidence)
  • Cold prevention/treatment (controversial; may slightly reduce duration)
  • Iron supplementation adjunct (enhances absorption)
  • Used as preservative in food and pharmaceutical products
  • Intravenous high-dose vitamin C in cancer (experimental, controversial)

4. Summary Tables

Table 1: Fat-Soluble Vitamins Summary

VitaminActive FormsMain FunctionsDeficiencyToxicityRDA (adults)Main Sources
ARetinol, retinal, retinoic acidVision, gene expression, immune function, epithelial integrityNight blindness, xerophthalmia, keratomalaciaHypervitaminosis A (teratogenic)700-900 μg RAELiver, fish oils, carrots, leafy greens
DCalcitriol [1,25(OH)₂D]Calcium/phosphate homeostasis, bone mineralization, immune modulationRickets (children), osteomalacia (adults)Hypercalcemia, soft tissue calcification600-800 IUSunlight, fatty fish, fortified foods
Eα-TocopherolAntioxidant (protects PUFA), membrane stabilityPeripheral neuropathy, hemolytic anemia (premature infants)Rare; bleeding risk at high doses15 mgVegetable oils, nuts, seeds
KPhylloquinone (K₁), menaquinones (K₂)Blood coagulation (factors II, VII, IX, X), bone metabolism (osteocalcin, MGP)Bleeding, hemorrhagic disease of newbornNone (K₁, K₂); menadione toxic90-120 μgLeafy greens, natto, gut flora

Table 2: Water-Soluble Vitamins Summary

VitaminActive CoenzymeMain FunctionsDeficiencyRDAMain Sources
B₁ (Thiamine)TPPCarbohydrate metabolism (PDH, α-KGDH), transketolaseBeriberi (wet/dry), Wernicke-Korsakoff1.1-1.2 mgPork, whole grains, legumes
B₂ (Riboflavin)FMN, FADRedox reactions (ETC, fatty acid oxidation, TCA)Ariboflavinosis (cheilosis, glossitis, dermatitis)1.1-1.3 mgDairy, eggs, liver, greens
B₃ (Niacin)NAD⁺, NADP⁺Redox reactions, ADP-ribosylation, sirtuinsPellagra (dermatitis, diarrhea, dementia, death)14-16 mg NEMeat, poultry, peanuts, fortified grains
B₅ (Pantothenic acid)CoA, ACPFatty acid metabolism, TCA, acetylcholine synthesisRare (burning feet syndrome)5 mg (AI)Widely distributed
B₆ (Pyridoxine)PLPAmino acid metabolism, neurotransmitter synthesis, heme synthesisSeborrheic dermatitis, neuropathy, microcytic anemia1.3-1.7 mgMeat, fish, potatoes, bananas
B₇ (Biotin)Biotinyl-lysine (biocytin)Carboxylation reactions (acetyl-CoA carboxylase, pyruvate carboxylase, etc.)Dermatitis, alopecia, metabolic acidosis30 μg (AI)Liver, egg yolk, nuts, legumes
B₉ (Folate)THFOne-carbon transfer, nucleotide synthesis (purines, dTMP), homocysteine metabolismMegaloblastic anemia, neural tube defects400 μg DFELeafy greens, legumes, fortified grains
B₁₂ (Cobalamin)Methylcobalamin, adenosylcobalaminMethionine synthase, methylmalonyl-CoA mutaseMegaloblastic anemia, neurological degeneration (subacute combined)2.4 μgMeat, fish, dairy, eggs (only animal sources)
C (Ascorbic acid)Ascorbate (redox)Collagen synthesis, antioxidant, carnitine synthesis, iron absorptionScurvy (hemorrhages, poor wound healing)75-90 mgCitrus fruits, berries, peppers, broccoli

Table 3: Vitamin Deficiencies and Clinical Features

VitaminDeficiency DiseaseKey Clinical Features
AXerophthalmiaNight blindness, Bitot's spots, corneal ulceration
DRickets/OsteomalaciaBowed legs, rachitic rosary, bone pain, fractures
E-Peripheral neuropathy, ataxia, hemolytic anemia (premature infants)
K-Bleeding, prolonged PT, hemorrhagic disease of newborn
B₁BeriberiPeripheral neuropathy (dry), heart failure (wet), Wernicke-Korsakoff syndrome
B₂AriboflavinosisCheilosis, angular stomatitis, magenta tongue, seborrheic dermatitis
B₃PellagraDermatitis, diarrhea, dementia (3 Ds)
B₆-Seborrheic dermatitis, microcytic anemia, peripheral neuropathy, seizures
B₇-Dermatitis, alopecia, metabolic acidosis
B₉Folate deficiencyMegaloblastic anemia, glossitis, neural tube defects in pregnancy
B₁₂Pernicious anemiaMegaloblastic anemia, neurological deficits (subacute combined degeneration)
CScurvyPerifollicular hemorrhages, bleeding gums, poor wound healing, fatigue

Table 4: Pharmacological Interactions of Vitamins with Drugs

VitaminDrug InteractionsClinical Significance
AOrlistat, cholestyramine, mineral oilReduce absorption
Retinoids (isotretinoin)Additive toxicity
DThiazidesHypercalcemia risk
Anticonvulsants, corticosteroidsReduce vitamin D levels/action
DigoxinHypercalcemia increases toxicity
EWarfarinIncreased bleeding risk
Antiplatelet drugsAdditive effect
KWarfarinAntagonizes anticoagulation (antidote)
Antibiotics, cephalosporinsMay increase INR
B₆Isoniazid, hydralazine, penicillamineAntagonize B6 (need supplementation)
Levodopa (without carbidopa)Reduces levodopa efficacy
B₉ (Folate)MethotrexateAntifolate effect (leucovorin rescue)
PhenytoinMay decrease phenytoin levels
Trimethoprim, pyrimethamineAdditive antifolate effect
B₁₂Metformin, PPIsReduce absorption (long-term use)
Nitrous oxideInactivates B12
CIronEnhances absorption
WarfarinHigh doses may interfere
Chemotherapy drugsPotential interaction (antioxidant)

5. Pharmaceutical Importance of Vitamins

ApplicationExamples
Nutritional supplementsMultivitamins, single vitamin supplements for deficiency prevention/treatment
Fortification of foodsFolic acid in grains, vitamin D in milk, B vitamins in cereals
Therapeutic uses (high-dose)Niacin for dyslipidemia, isotretinoin for acne, calcitriol for renal osteodystrophy, vitamin K for warfarin reversal
Topical preparationsRetinoids for acne/photoaging, vitamin E for skin, panthenol for wound healing
Antioxidant formulationsVitamin E, vitamin C in skin care and pharmaceutical products
Diagnostic markersVitamin levels measured to assess nutritional status, malabsorption
Drug interactionsManaging vitamin status in patients on interacting medications
Parenteral nutritionEssential components of TPN (total parenteral nutrition)
AntidotesVitamin K for warfarin overdose, hydroxocobalamin for cyanide poisoning
Cancer therapyMethotrexate with leucovorin rescue; retinoids for leukemia differentiation

References

  1. Lippincott Williams & Wilkins. (2020). Lippincott's illustrated reviews: Biochemistry. (Chapters on Vitamins)

  2. Berg, J. M., Tymoczko, J. L., & Gatto, G. J. (2019). Stryer's biochemistry (8th ed.). W. H. Freeman and Company. (Chapters on Vitamins and Cofactors)

  3. Nelson, D. L., & Cox, M. M. (2017). Lehninger principles of biochemistry (7th ed.). W. H. Freeman and Company. (Chapters on Vitamins and Minerals)

  4. Rodwell, V. W., Bender, D. A., Botham, K. M., Kennelly, P. J., & Weil, P. A. (2017). Harper's illustrated biochemistry (31st ed.). McGraw-Hill Education. (Chapters on Vitamins)

  5. Devlin, T. M. (2016). Textbook of biochemistry with clinical correlations (8th ed.). Wiley-Liss. (Chapters on Vitamins and Their Functions)

  6. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. (1998-2011). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline; Vitamin C, Vitamin E, Selenium, and Carotenoids; Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc; Calcium and Vitamin D. National Academies Press.

  7. Kumar, V., Abbas, A. K., & Aster, J. C. (2020). Robbins & Cotran pathologic basis of disease (10th ed.). Elsevier. (Clinical correlations of vitamin deficiencies)

  8. Ball, G. F. M. (2004). Vitamins: Their role in the human body. Blackwell Publishing.

  9. Combs, G. F., & McClung, J. P. (2017). The vitamins: Fundamental aspects in nutrition and health (5th ed.). Academic Press.


Recommended Textbooks for Further Reading:

  • Lippincott Williams & Wilkins. (2020). Lippincott's illustrated reviews: Biochemistry. (Excellent for visual summaries and clinical notes on vitamins)
  • Rodwell, V. W., et al. (2017). Harper's illustrated biochemistry (31st ed.). (Strong clinical emphasis with vitamin chapters)
  • Combs, G. F., & McClung, J. P. (2017). The vitamins: Fundamental aspects in nutrition and health (5th ed.). (Comprehensive coverage of all vitamins)